Amylyx Pharmaceuticals Financial Statements From 2010 to 2026
| AMLX Etf | USD 14.67 0.38 2.66% |
Gross Profit -92.7 M | Market Capitalization 1.6 B | Enterprise Value Revenue 6.4 K | Revenue | Earnings Share (1.72) |
Check Amylyx Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amylyx Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Amylyx financial statements analysis is a perfect complement when working with Amylyx Pharmaceuticals Valuation or Volatility modules.
This module can also supplement Amylyx Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Amylyx Pharmaceuticals Technical models . Check out the analysis of Amylyx Pharmaceuticals Correlation against competitors. Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Amylyx Etf
Amylyx Pharmaceuticals financial ratios help investors to determine whether Amylyx Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amylyx with respect to the benefits of owning Amylyx Pharmaceuticals security.